scholarly article | Q13442814 |
P2093 | author name string | M C Mihm | |
D F Roses | |||
A B Cosimi | |||
M N Harris | |||
R A Malt | |||
A W Kopf | |||
R J Friedman | |||
W C Wood | |||
R A Lew | |||
A J Sober | |||
S L Gumport | |||
T B Fitzpatrick | |||
A Postel | |||
C L Day | |||
D Rigel | |||
F Gorstein | |||
F M Golomb | |||
J W Raker | |||
M M Mintzis | |||
P Hennessey | |||
T J Harrist | |||
R W Grier | |||
P2860 | cites work | Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma | Q24540048 |
The histogenesis and biologic behavior of primary human malignant melanomas of the skin | Q34054176 | ||
Malignant melanoma. Prognostic significance of "microscopic satellites" in the reticular dermis and subcutaneous fat. | Q36657059 | ||
Tumor thickness as a guide to surgical management of clinical stage I melanoma patients | Q41486624 | ||
A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma | Q41711591 | ||
The regressing thin malignant melanoma: a distinctive lesion with metastatic potential | Q43877987 | ||
Prognostic factors in cutaneous malignant melanoma in stage I. A clinical, morphological and multivariate analysis | Q44397348 | ||
A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods | Q52437315 | ||
Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51 - 3.39 mm). A conceptual model for tumor growth and metastasis. | Q52730145 | ||
The Natural Break Points for Primary-Tumor Thickness in Clinical Stage I Melanoma | Q52732552 | ||
A prognostic model for clinical stage I melanoma of the trunk. Location near the midline is not an independent risk factor for recurrent disease. | Q52735595 | ||
Malignant melanoma of the extremities: A clinicopathologic study using levels of invasion (microstage) | Q66908743 | ||
Stage I melanoma of the limbs. Immediate versus delayed node dissection | Q67250734 | ||
The spaghetti theory of leadership (and other saucy ideas) | Q68318462 | ||
Prognostic factors for melanoma patients with lesions 0.76 - 1.69 mm in thickness. An appraisal of "thin" level IV lesions | Q70269701 | ||
A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II) | Q70717837 | ||
A prognostic model for clinical stage I melanoma of the upper extremity. The importance of anatomic subsites in predicting recurrent disease | Q70717847 | ||
A prognostic model for clinical stage I melanoma of the lower extremity. Location on foot as independent risk factor for recurrent disease | Q70743908 | ||
Malignant melanoma patients with positive nodes and relatively good prognoses: Microstaging retains prognostic significance in clinical stage I melanoma patients with metastases to regional nodes | Q70755933 | ||
A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES | Q78539166 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | multivariate statistics | Q1952580 |
P304 | page(s) | 44-49 | |
P577 | publication date | 1982-01-01 | |
P1433 | published in | Annals of Surgery | Q4767866 |
P1476 | title | A multivariate analysis of prognostic factors for melanoma patients with lesions greater than or equal to 3.65 mm in thickness. The importance of revealing alternative Cox models | |
P478 | volume | 195 |
Q70299689 | An evaluation of vertical growth in thin superficial spreading melanomas by sequential serial microscopic sections |
Q50854697 | Analysis of histopathological factors associated with prolonged survival of 10 years or more for patients with thick melanomas (> 5 mm). |
Q40347714 | Classification of malignant melanomas according to the histologic morphology of melanoma nodules |
Q39736224 | Cutaneous malignant melanoma in the older patient. |
Q67487509 | Dominant rearrangements among human tumor-infiltrating lymphocytes. Analysis of T-cells derived from 32 patients with melanoma, lung, and renal cell carcinoma |
Q40717524 | Elective lymph node dissection for melanoma |
Q72528647 | Failure of FAB classification to predict relapse-free survival in acute leukemia |
Q39477930 | Immunology and immunotherapy of human malignant melanoma. |
Q69597256 | Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomized study |
Q52871928 | Malignant melanoma prognostic factors 7: elective lymph node dissection. |
Q44646044 | Melanoma of palms, soles, and nail-beds |
Q51193234 | One-year follow-up of panic disorder. Outcome and prognostic factors. |
Q34446288 | Overview analysis of adjuvant therapies for melanoma--a special reference to results from vaccinia melanoma oncolysate adjuvant therapy trials |
Q71931085 | Pathology of malignant melanoma |
Q71767718 | Predictors of late deaths among patients with clinical stage I melanoma who have not had bony or visceral metastases within the first 5 years after diagnosis |
Q40151405 | Primary cutaneous malignant melanoma |
Q52568001 | Prognostic Significance of DNA Aneuploidy in Stage I Cutaneous Melanoma |
Q34964449 | Prognostic factors |
Q55042733 | Prognostic factors for metastasis in cutaneous melanoma. |
Q52730145 | Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51 - 3.39 mm). A conceptual model for tumor growth and metastasis. |
Q35105671 | Prognostic factors in primary cutaneous melanoma |
Q36381934 | Prognosticators of melanoma, the melanoma report, and the sentinel lymph node |
Q26799073 | Reflections on the Histopathology of Tumor-Infiltrating Lymphocytes in Melanoma and the Host Immune Response |
Q71688574 | Regression in malignant melanoma |
Q47744033 | Sentinel Lymph Node Status is a Main Prognostic Parameter Needful for the Correct Staging of Patients with Melanoma Thicker than 4 mm: Single-Institution Experience and Literature Meta-Analysis |
Q55476901 | Studies of the mechanism of cytolysis by tumour-infiltrating lymphocytes. |
Q72528649 | Subsite concept for metastases in clinical stage I melanoma |
Q39726052 | The clinical recognition and prognostic factors of primary cutaneous malignant melanoma |
Q40233231 | The extent of primary melanoma excision. A re-evaluation--how wide is wide? |
Q45411290 | The highly attenuated vaccinia virus strain modified virus Ankara induces apoptosis in melanoma cells and allows bystander dendritic cells to generate a potent anti-tumoral immunity |
Q70454401 | The incidental malignant melanoma |
Q70454611 | The incidental malignant melanoma |
Q41903179 | The prognosis of primary and metastasising melanoma. An evaluation of the TNM classification in 2,495 patients |
Search more.